Key result
Estimated ApoB-enhanced lipid profiles predict incident HF up to 36 months early with ~0.93 AUROC.
Why the study?
Patients with or at risk of HF often exhibit unexpectedly low LDL-C levels despite developing cardiovascular disease. This study examined how well retrospective lipid panel measurements supplemented with ApoB predict an initial HF event across several pre-diagnosis time windows.
Can machine learning applied to routine lipid panels supplemented with estimated ApoB predict an initial heart failure event up to 36 months in advance and clarify the role of the cholesterol paradox?
Cohort (n=53,275)
Yes
Can machine learning applied to routine lipid panels supplemented with estimated ApoB predict an initial heart failure event up to 36 months in advance and clarify the role of the cholesterol paradox?
Routine lipid panels supplemented with formula-estimated ApoB can accurately distinguish future heart failure patients from non-CVD controls up to 36 months before diagnosis, demonstrating that paradoxically lower LDL-C alongside higher triglycerides and lower HDL-C precedes initial HF events.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for pre-HF lipid signatures; leaves open prospective validation before any clinical use.
In cardiovascular medicine, low-density lipoprotein cholesterol (LDL-C) is the main lipid marker used in routine screening to assess cardiovascular risk and guide preventive treatment and dietary changes. An increasing number of studies have recently documented the cholesterol paradox: patients with or at risk of heart failure (HF) often have unexpectedly low levels of LDL-C despite leading to cardiovascular diseases. This paper examines how well retrospective lipid panel measurements, supplemented with apolipoprotein B (ApoB), can predict an initial heart failure (HF) event in several pre-diagnosis time windows, using age-matched patient data from Electronic Health Records (EHRs). This retrospective study uses lipid profiles from multicenter nationwide EHRs from the All of Us Research Program. We apply machine learning and explainable AI (SHAP) to lipid-based prediction and to interpret cholesterol contributions to the diagnosis of first heart failure (HF). One experiment predicts the diagnosis of HF in 36 months; the other distinguishes HF patients from people who have never been diagnosed with cardiovascular disease. A baseline lipid panel that includes ApoB predicts the first HF event up to 36 months in advance, achieving an AUC of 0.624 in men and 0.627 in women. Compared to a group of the same age without previous cardiovascular disease, a lipid profile including ApoB predicts a first HF event with a substantially higher AUC: 0.937 for men and 0.925 for women. Shapley value analyses suggest that higher triglycerides and lower HDL and LDL levels are linked to subsequent HF events, with LDL appearing as the strongest yet counterintuitive predictor. ApoB ranks second in importance; in males, higher ApoB is associated with a greater risk of HF, unlike LDL. In general, the study highlights an unexpected association with LDL and emphasizes the prognostic utility of sex-specific metabolic indicators (TG, HDL) for HF using routinely collected clinical data.
No takes yet. Share an insight, caveat, or question.
Hou et al. (2026) conducted a cohort in Initial heart failure (HF) diagnosis (n=53,275). XGBoost machine learning model using standard lipid panel (LDL-C, HDL-C, TG) supplemented with estimated Apolipoprotein B (ApoB) vs. Age-matched participants without cardiovascular disease (Task II) or earlier pre-diagnosis lipid records >6-36 months prior to HF (Task I) was evaluated on Prediction of first heart failure (HF) diagnosis up to 36 months in advance (AUROC 0.937 in men and 0.925 in women (vs non-CVD); AUROC 0.624 in men and 0.627 in women (36-month within-HF window), p=<0.001). Lipid profiles supplemented with estimated ApoB predicted first heart failure up to 36 months in advance with an AUROC of 0.937 in men and 0.925 in women compared to non-CVD controls.
Synapse has enriched 10 related papers. Consider them for comparative context: